CCR Translation for This Article from HSP90 Inhibition Is Effective in Breast Cancer: A Phase II Trial of Tanespimycin (17-AAG) Plus Trastuzumab in Patients with HER2-Positive Metastatic Breast Cancer Progressing on Trastuzumab
Authors:
- Shanu ModiSMShanu Modi
- Alison StopeckASAlison Stopeck
- Hannah LindenHLHannah Linden
- David SolitDSDavid Solit
- Sarat ChandarlapatySCSarat Chandarlapaty
- Neal RosenNRNeal Rosen
- Gabriella D'AndreaGDGabriella D'Andrea
- Maura DicklerMDMaura Dickler
- Mary E. MoynahanMMMary E. Moynahan
- Steven SugarmanSSSteven Sugarman
- Weining MaWMWeining Ma
- Sujata PatilSPSujata Patil
Open Access
- 31 March 2023
- other
- Published by American Association for Cancer Research (AACR)